Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

Subclinical Primary Aldosteronism and Cardiovascular Health: A Population-Based Cohort Study

  • Gregory L. Hundemer
  • , Mohsen Agharazii
  • , Francois Madore
  • , Anand Vaidya
  • , Jenifer M. Brown
  • , Alexander A. Leung
  • , Gregory A. Kline
  • , Eric Larose
  • , Marie-Eve Piche
  • , Andrew M. Crean
  • , Julie L. V. Shaw
  • , Tim Ramsay
  • , Bernhard Hametner
  • , Siegfried Wassertheurer
  • , Manish M. Sood
  • , Swapnil Hiremath
  • , Marcel Ruzicka
  • , Remi Goupil
  • Clinical Epidemiology Program, Ottawa Hospital Research Institute
  • Department of Medicine, Division of Nephrology, University of Ottawa
  • Centre Hospitalier Universitaire de Québec (CHUQ), University Laval
  • Hôpital du Sacré-Coeur, Montréal
  • Division of Newborn Medicine, Department of Pediatrics, Brigham and Women’s Hospital, Harvard Medical School
  • Department of Medicine, Division of Endocrinology and Metabolism (A.A.L., G.A.K.), Cumming School of Medicine, University of Calgary
  • Department of Community Health Sciences (A.A.L.), Cumming School of Medicine, University of Calgary
  • Department of Medicine, Division of Cardiology, University Laval
  • Institute of Cardiology and Pneumology, University Laval
  • Division of Cardiovascular Medicine, Ottawa Heart Institute, University of Ottawa
  • Department of Pathology and Laboratory Medicine, Division of Biochemistry, Ottawa Hospital
  • Eastern Ontario Regional Laboratory Association (EORLA)

Publikation: Beitrag in FachzeitschriftArtikelBegutachtung

Abstract

BACKGROUND:
Primary aldosteronism, characterized by overt renin-independent aldosterone production, is a common but underrecognized form of hypertension and cardiovascular disease. Growing evidence suggests that milder and subclinical forms of primary aldosteronism are highly prevalent, yet their contribution to cardiovascular disease is not well characterized.

METHODS:
This prospective study included 1284 participants between the ages of 40 and 69 years from the randomly sampled population-based CARTaGENE cohort (Québec, Canada). Regression models were used to analyze associations of aldosterone, renin, and the aldosterone-to-renin ratio with the following measures of cardiovascular health: arterial stiffness, assessed by central blood pressure (BP) and pulse wave velocity; adverse cardiac remodeling, captured by cardiac magnetic resonance imaging, including indexed maximum left atrial volume, left ventricular mass index, left ventricular remodeling index, and left ventricular hypertrophy; and incident hypertension.

RESULTS:
The mean (SD) age of participants was 54 (8) years and 51% were men. The mean (SD) systolic and diastolic BP were 123 (15) and 72 (10) mm Hg, respectively. At baseline, 736 participants (57%) had normal BP and 548 (43%) had hypertension. Higher aldosterone-to-renin ratio, indicative of renin-independent aldosteronism (ie, subclinical primary aldosteronism), was associated with increased arterial stiffness, including increased central BP and pulse wave velocity, along with adverse cardiac remodeling, including increased indexed maximum left atrial volume, left ventricular mass index, and left ventricular remodeling index (all P<0.05). Higher aldosterone-to-renin ratio was also associated with higher odds of left ventricular hypertrophy (odds ratio, 1.32 [95% CI, 1.002–1.73]) and higher odds of developing incident hypertension (odds ratio, 1.29 [95% CI, 1.03–1.62]). All the associations were consistent when assessing participants with normal BP in isolation and were independent of brachial BP.

CONCLUSIONS:
Independent of brachial BP, a biochemical phenotype of subclinical primary aldosteronism is negatively associated with cardiovascular health, including greater arterial stiffness, adverse cardiac remodeling, and incident hypertension.
OriginalspracheEnglisch
Seiten (von - bis)124-134
Seitenumfang11
FachzeitschriftCirculation
Volume149
Issue2
Frühes Online-Datum30 Nov. 2023
DOIs
PublikationsstatusVeröffentlicht - 9 Jan. 2024

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

  1. SDG 3 – Gute Gesundheit und Wohlergehen
    SDG 3 – Gute Gesundheit und Wohlergehen

Research Field

  • Medical Signal Analysis
  • Nicht definiert

Web of Science subject categories (JCR Impact Factors)

  • Cardiac & Cardiovascular Systems
  • Peripheral Vascular Disease

Fingerprint

Untersuchen Sie die Forschungsthemen von „Subclinical Primary Aldosteronism and Cardiovascular Health: A Population-Based Cohort Study“. Zusammen bilden sie einen einzigartigen Fingerprint.

Diese Publikation zitieren